Health Law & Business

Cancer Therapy Triggers Battle Over Innovation, Medicare Costs

April 29, 2019, 10:55 AM

Cancer centers and hospitals, growing frustrated with Medicare’s reluctance to pay full freight for an innovative cancer treatment, are asking lawmakers in Congress to pressure regulators.

The new therapy, known as CAR-T, effectively trains a patient’s immune system to kill cancer cells. It came up explicitly in 18 lobbying filings for the first three months of 2019 on behalf of the Cleveland Clinic, Memorial Sloan-Kettering Cancer Center, and the H. Lee Moffitt Cancer Center & Research Institute, among other organizations. That’s up from just two such disclosures filed with the House of Representatives clerk during the same time period in...

To read the full article log in. To learn more about a subscription click here.